Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New method for testing drug function

30.01.2018

Findings from basic research could facilitate drug development

The research group of Martin Denzel, group leader at the Max Planck Institute for Biology of Aging in Cologne has developed a method for defining the effectiveness of medicines.
The idea is funded by the EU with 150,000 euros for one year and enables the establishment of a company with which this method should become ready for the market.


The scientists Martin Denzel (links) und Moritz Horn from the Max Planck Institute for Biology of Aging start up the new company ACUS

©Max Planck Institute for Biology of Ageing

“This is a once-in-a-lifetime opportunity”, says Martin Denzel about his new project which he advances with his postdoc Moritz Horn: the foundation of the ACUS Laboratories. The idea is based on the development of a method that will have great benefit for research and pharmaceutical companies.

The main focus during drug development for cancer for example lies mainly on the effectiveness of the substance. Where and how the drug actually works in the cell remains often unknown. ACUS Laboratories will close this gap of knowledge since their new method allows the precise localization and protein binding of the substance within the cell. With that not only the functionality of the drug can be revealed but also the drug can be further optimized for the depletion of undesired side effects.

“With our method, we can literally find the needle in the haystack", explains Denzel. This also explains the companies name ACUS Laboratories. “Acus is latin for needle”, adds the scientist.

The project has now also gained the attention from the European Union and was awarded with the “Proof of Concept” Grant. This research funding is only available for scientists who are already funded by the EU. With 150,000 euros for one year the grant offers the researchers the required freedom they need to found their company.

"During this year, Moritz Horn will drive the founding of the company," explains Denzel. For this, market analysis has to be carried out, a business plan needs to be developed and the new service further optimized.

An important step has already been completed: Martin Denzel and Moritz Horn found partners from science and industry. They work together with Josef Penninger and Ullrich Elling from the Institute of Molecular Biotechnology in Vienna, Austria, who took a great part in the development of the new technique.

The Max Planck Innovation GmBH will also support the company founders together with the Lead Discovery Center. Furthermore, another big pharmaceutical company has expressed their interest in the new development.

This project of Martin Denzel shows that basic research, which initially focuses on pure knowledge, can produce results that have a high economic relevance. "We believe that our method has the potential to become a new standard procedure in drug development," says Denzel.

Dr. Annegret Burkert | Max-Planck-Institut für Biologie des Alterns
Further information:
http://www.age.mpg.de

More articles from Life Sciences:

nachricht Nonstop Tranport of Cargo in Nanomachines
20.11.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik

nachricht Researchers find social cultures in chimpanzees
20.11.2018 | Universität Leipzig

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Nonstop Tranport of Cargo in Nanomachines

20.11.2018 | Life Sciences

Researchers find social cultures in chimpanzees

20.11.2018 | Life Sciences

When AI and optoelectronics meet: Researchers take control of light properties

20.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>